O. Moldovan et al.
(90% EtOH/aq. NH3 25%). IR νmax. (KBr) 3400 (s), 2922 D-NH), 93.9, 94.0 94.1 (C-2, D-NH), 123.2, 123.5 (C-2,
(m), 2855 (s), 1548(s), 1501 (s), 1444 (s), 1346 (s), -6, p-NPh), 127.3, 127.6 (C-3, -5, p-NPh), 147.0, 147.1
1274 (m), 1174 (m), 1106 (m), 1056 (m), 1027 (m), 875 (C-1, -4, p-NPh), 164.5 (C-2, s-triazine), 165.4, 165.6
(w), 852 (w), 810 (m), 744 (w),711 (m), 583 (w) cm-1. (C-4, -6, s-triazine) ppm. MS (ESI+), m/z (rel. int. %)
1H NMR (500 MHz, [D6]DMSO, 363 K): δH 1.21 (3H, s, 505.3 [M++H] (100), 403.2 (25), 224.0 (12), 208.0 (37).
Me), 2.65 (4H, t, 3JH,H=5.0 Hz, H-3, -5, Piperazine), 3.47 [α]D25=+42 (0.5% DMSO).
2
3
(2H, d, JH,H=10.5 Hz, CH2OH), 3.48 (4H, t, JH,H=5.0
1-{6-{[1,3-Dihydroxy-2-(hydroxymethyl)prop-2-yl]
2
Hz, H-2, -6, Piperazine), 3.56 (2H, d, JH,H=10.5 Hz, amino}-4-{[(4S,5S)-4-(4-nitrophenyl)-1,3-dioxan-5-yl]
CH2OH), 4.02 (1H, d, 2JH,H=11.0 Hz, H-6-a, D-NH), 4.11 amino}-s-triazin-2-yl}-piperazine 4c (86%) yellowish
(1H, dd, 3JH,H=1.5 Hz, 2JH,H = 11.5 Hz, H-6-e, D-NH), 4.41 powder, mp 146-157°C (column chromatography,
3
(1H, d, JH,H = 9.0 Hz, H-5-e, D-NH), 4.54 (3H, bs, OH, EtOH : aq. NH3 25% 9:1). [Found: C 50.11, H 5.88, N
Pip-NH), 5.00 (1H, d, 2JH,H=6.5 Hz, H-2-a, D-NH), 5.225 21.90; C21H30N8O7 (506.22) requires: C 49.80, H 5.97,
2
(1H, s, H-4-a, D-NH), 5.230 (1H,d, JH,H=5.5 Hz, H-2-e, N 22.12%]. Rf 0.71 (90% EtOH/aq. NH3 25%). IR νmax.
D-NH), 5.43 (1H, s, SER-NH), 5.49 (1H, d, 3JH,H=9.5 Hz, (KBr) 3392 (m), 2943 (m), 2856 (m), 1549 (s), 1504 (s),
3
D-NH), 7.62 (2H, d, JH,H=9.0 Hz, H-2, -6, p-NPh), 8.11 1446 (m), 1346 (s), 1273 (m), 1174 (m), 1105 (m), 1025
(2H, d, 3JH,H=8.5 Hz, H-3, -5, p-NPh) ppm; 13C NMR (125 (m), 872 (w), 852 (w), 809 (m), 744 (w), 711 (w), 584
MHz, [D6]DMSO, 298 K): δC 19.2 (Me), 44.2, 44.3 (C-2, (w) cm-1. 1H NMR (500 MHz, [D6]DMSO, 353 K): δH 2.65
3
-6, Piperazine), 45.8, 45.9, 46.0 (C-3, -5, Piperazine), (3H, t, JH,H=4.8 Hz, H-3, -5, Piperazine), 2.68 (1H, s,
48.8, 48.9 (C-5, D-NH), 57.9 (C-2, SER-NH), 64.6, 64.9 Pip-NH), 3.46 (4H, t, 3JH,H=5.0 Hz, H-2, -6, Piperazine),
(CH2OH), 70.5, 70.6, 70.8, 71.0 (C-6, D-NH), 78.5, 78.6, 3.30 (3H, bs, OH), 3.62 (6H, s, CH2OH), 4.02 (1H, d,
2
78.9, 79.0 (C-4, D-NH), 93.9, 94.0, 94.1 (C-2, D-NH), 2JH,H=11.0 Hz, H-6-a, D-NH), 4.11 (1H, JH,H=11.0 Hz,
123.2, 123.5 (C-2, -6, p-NPh), 127.4, 127.6 (C-3, -5, H-6-e, D-NH), 4.40 (1H, bd, 3JH,H = 7.5 Hz, H-5-e, D-NH),
2
p-NPh), 147.0, 147.1 (C-1, -4, p-NPh), 164.17, 164.22, 5.00 (1H, d, JH,H=6.5 Hz, H-2-a, D-NH), 5.22 (1H, s,
2
164.3, 164.5 (C-2, s-triazine), 165.3, 165,4 (C-4, -6, H-4-a, D-NH), 5.23 (1H, d, JH,H=5.5 Hz, H-2-e, D-NH),
s-triazine) ppm. MS (ESI+), m/z (rel. int. %) 491.2 [M++H] 5.43 (1H, s, SER-NH), 5.61 (1H, d, 3JH,H=9.5 Hz, D-NH),
(100), 403.2 (22), 208.0 (29). [α]D25=+28 (0.5% DMSO). 7.63 (2H, d, JH,H=9.0 Hz, H-2, -6, p-NPh), 8.12 (2H, d,
3
1-{6-{[1-Hydroxy-2-(hydroxymethyl)but-2-yl]amino}- 3JH,H=8.0 Hz, H-3, -5, p-NPh) ppm; 13QC NMR (75 MHz,
4-{[(4S,5S)-4-(4-nitrophenyl)-1,3-dioxan-5-yl]amino}-s- [D6]DMSO, 298 K): δC 43.9 (2C, C-2, -6, Piperazine),
triazin-2-yl}-piperazine 4b (84%) yellowish powder, mp 45.4 (2C, C-3, -5, Piperazine), 48.8 (1C, C-5, D-NH),
125-130°C (column chromatography, EtOH : aq. NH3 61.0, 61.3 (4C, C-2, CH2OH, SER-NH), 70.5, 70.7 (1C,
25% 9:1). [Found: C 51.99, H 6.22, N 21.95; C22H32N8O6 C-6, D-NH), 78.4, 78,8 (1C, C-4, D-NH), 93.9 (1C,
(504.24) requires: C 52.37, H 6.39, N 22.21%]. Rf 0.66 C-2, D-NH), 123,1, 123,3 (2C, C-2, -6, p-NPh), 127.1,
(90% EtOH/aq. NH3 25%). IR νmax. (KBr) 3401 (s), 2966 127.4 (2C, C-3, -5, p-NPh), 146.9 (2C, C-1, -4, p-NPh),
(m), 2856 (s), 1552 (s), 1500 (s), 1445 (s), 1346 (s), 1174 164.2 (1C, C-2, s-triazine), 165.0, 165.2, 165.4, 165.5
(m), 1106 (m), 1061 (m), 1026 (m), 873 (w), 852 (w), 809 (2C, C-4, -6, s-triazine) ppm. MS (DCI positive, 200
(m), 744 (w), 710 (w), 583 (w) cm-1. 1H NMR (500 MHz, eV, isobutane), m/z (rel. int. %) 563 [M++iBuH-2 H] (9),
3
[D6]DMSO, 363 K): δH 0.74 (3H, t, JH,H = 7.3 Hz, CH3), 507 [M++H] (100), 489 (10), 477 (10), 404 (10),282 (5),
1.73, 1.74 (2H, 2×q, JH,H=7.5 Hz, CH2CH3), 2.69 (4H, 225 (10), 115 (8), 104 (20), 87 (75). [α]D25=+24 (0.5%
3
3
t, JH,H=5.0 Hz, H-3, -5, Piperazine), 3.49-3.51 (6H, m, DMSO).
CH2OH, H-2, -6, Piperazine), 3.56 (2H, d, 2JH,H=10.5 Hz,
1-{6-{[1,3-Dihydroxy-2-(methyl)prop-2-yl]amino}-
CH2OH), 4.02 (1H, d, 2JH,H=11.5 Hz, H-6-a, D-NH), 4.12 4-{{[(2R,4S,5S)-5-(dimethylamino)-4-(4-nitrophenyl)-
(1H, dd, 3JH,H=1.5 Hz, 2JH,H = 11.5 Hz, H-6-e, D-NH), 4.41 1,3-dioxan-2-yl]methy}lamino}-s-triazin-2-yl}-piperazine
3
(1H, d, JH,H = 9.0 Hz, H-5-e, D-NH), 4.54 (3H, bs, OH, 5a (71%) yellow powder, mp 118-123°C (column
2
Pip-NH), 5.00 (1H, d, JH,H=6.5 Hz, H-2-a, D-NH), 5.23 chromatography, EtOH : aq. NH3 25% 9:1). [Found: C
2
(1H, d, JH,H=5.5 Hz, H-2-e, D-NH), 5.24 (1H, s, H-4a, 52.88, H 7.07, N 22.85; C24H37N9O6 (547.29) requires:
D-NH), 5.35 (1H, s SER-NH), 5.52 (1H, d, 3JH,H=9.5 Hz, C 52.64, H 6.81, N 23.02%]. Rf 0.57 (90% EtOH/aq.
3
D-NH), 7.62 (2H, d, JH,H=8.0 Hz, H-2, -6, p-NPh), 8.10 NH3 25%). IR νmax. (KBr) 3295 (s), 2932 (s), 2860 (s),
3
(2H, d, JH,H=8.5 Hz, H-3, -5, p-NPh) ppm; 13C NMR 1670 (m), 1548 (s), 1516 (s), 1444 (s), 1348 (s), 1296
(125 MHz, [D6]DMSO, 298 K): δC 8.1 (CH3), 23.4, 23.46, (m), 1151 (m), 1113 (m), 1055 (m), 1016 (m), 852 (m),
1
23.54 (CH2CH3), 43.5, 44.0 (C-2, -6, Piperazine), 45.45, 809 (m), 710 (m), 668 (w), 572 (w) cm-1. H NMR (500
45.55, 45.64, 45.7 (C-3, -5, Piperazine), 48.8, 48,9 (C-5, MHz, [D6]DMSO, 353 K): δH 1.27 (3H, s, Me), 2.23 (6H,
D-NH), 60.2 (C-2, SER-NH), 62.5, 62.9 (CH2OH), 70.5, s, NMe2), 2.69 (4H, t, 3JH,H=4.8 Hz, H-3, -5, Piperazine),
3
70,6 70.8, 70.9 (C-6, D-NH), 78.5, 78.95, 79.04 (C-4, 2.86 (1H, dd as t, JH,H=2.8 Hz, H-5-e, D-NH), 3.496
1123